Post-transplantation Osteoporosis / 대한이식학회지
The Journal of the Korean Society for Transplantation
;
: 239-244, 2011.
Article
in Korean
| WPRIM
| ID: wpr-133172
ABSTRACT
Transplantation has become an established treatment in many end-stage organ diseases and hematologic diseases. The survival rate after transplantation has greatly improved due to the development of newer immunosuppressive drugs bringing the issues of post-transplantation complications to light. Osteoporosis and osteoporosis-related fragility fractures are feared complications, greatly influencing the quality of life in transplant patients. In addition to the conventional risk factors for osteoporosis, post-transplantation osteoporosis is caused by factors related to end-stage organ disease prior to transplantation and immunosuppressive therapy after transplantation. Since the rate of bone loss in post-transplantation osteoporosis is thought to be at the greatest immediately following transplantation, early measures need to be taken to prevent and treat post-transplantation osteoporosis. Both conventional and newer therapeutics for osteoporosis are largely being studied and used in practice for the prevention and treatment of post-transplantation osteoporosis.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Osteoporosis
/
Quality of Life
/
Survival Rate
/
Risk Factors
/
Tacrolimus
/
Cyclosporine
/
Transplants
/
Hematologic Diseases
/
Light
Type of study:
Etiology study
/
Risk factors
Limits:
Humans
Language:
Korean
Journal:
The Journal of the Korean Society for Transplantation
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS